COOK IRELAND LTD ZILVER PTX DRUG-ELUTING PERIPHERAL STENT; NIU STENT, SUPERFICIAL FEMORAL ARTERY, DRUG-ELUTING
|
Back to Search Results |
|
Catalog Number ZIV6-35-125-6.0-120-PTX |
Device Problem
Occlusion Within Device (1423)
|
Patient Problems
Occlusion (1984); Surgical procedure, additional (2564)
|
Event Date 07/09/2013 |
Event Type
Injury
|
Event Description
|
On (b)(6) 2012, the complaint ptx stent was placed in right upper sfa, (b)(6) 2013 although no symptoms were observed to the patient, restenosis (50-99%) in the lesion where the complaint stent was implanted was confirmed, (b)(6) 2013 pta was performed against the restenosis and the condition of the patient recovered.No further adverse effects to the patient have been reported as occurring.
|
|
Manufacturer Narrative
|
(b)(4).The zilver ptx device involved in this complaint was implanted in the patient therefore is not available for evaluation.With the info provided, a document based investigation was carried out.Although requested images relating to this event have not been received.It may be noted that re-stenosis is a common adverse event of endovascular procedures and can be caused by injury to the vessel (e.G.During pta and/or stenting).Vessel injury provokes an inflammatory response that leads (or amplifies) to the restenosis process.Restenosis of the stented artery is a known potential adverse event associated with the placement of this device.The complaint is confirmed based on customer testimony.A review of the manufacturing records revealed no discrepancies related to this complaint issue.Prior to distribution, all zilver ptx devices are subject to visual inspection and functional checks to ensure device integrity.Due to lack of images no other comments can be provided at this time.Quality engineering will continue to monitor complaints for this nature for potential emerging trends.
|
|
Search Alerts/Recalls
|
|
|